Genetics of cystic fibrosis: CFTR mutation classifications toward genotype-based CF therapies.: Genetics of CF

Pascale Fanen 1, * Adeline Wohlhuter-Haddad 2 Alexandre Hinzpeter 3
* Auteur correspondant
1 INSERM U955, équipe 11
Dépatement de génétique, IMRB - Institut Mondor de Recherche Biomédicale
2 INSERM U955, équipe 11
Department of Physiology, IMRB - Institut Mondor de Recherche Biomédicale
3 INSERM U955, équipe 11
IMRB - Institut Mondor de Recherche Biomédicale
Abstract : Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which encodes an epithelial anion channel. Since the identification of the disease in 1938 and up until 2012, CF patients have been treated exclusively with medications aimed at bettering their respiratory, digestive, inflammatory and infectious symptoms. The identification of the CFTR gene in 1989 gave hopes of rapidly finding a cure for the disease, for which over 1950 mutations have been identified. Since 2012, recent approaches have enabled the identification of small molecules targeting either the CFTR protein directly or its key processing steps, giving rise to novel promising therapeutic tools. This review presents the current CFTR mutation classifications according to their clinical consequences and to their effect on the structure and function of the CFTR channel. How these classifications are essential in the establishment of mutation-targeted therapeutic strategies is then discussed. The future of CFTR-targeted treatment lies in combinatory therapies that will enable CF patients to receive a customized treatment.
Type de document :
Article dans une revue
International Journal of Biochemistry and Cell Biology, Elsevier, 2014, 52, pp.94-102. 〈10.1016/j.biocel.2014.02.023〉
Liste complète des métadonnées

Littérature citée [77 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01059046
Contributeur : Georges Guellaen <>
Soumis le : vendredi 29 août 2014 - 11:09:29
Dernière modification le : mercredi 27 janvier 2016 - 17:35:32
Document(s) archivé(s) le : mardi 11 avril 2017 - 21:03:45

Fichier

Fanen_IJCBC_14_HAL.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Pascale Fanen, Adeline Wohlhuter-Haddad, Alexandre Hinzpeter. Genetics of cystic fibrosis: CFTR mutation classifications toward genotype-based CF therapies.: Genetics of CF. International Journal of Biochemistry and Cell Biology, Elsevier, 2014, 52, pp.94-102. 〈10.1016/j.biocel.2014.02.023〉. 〈inserm-01059046〉

Partager

Métriques

Consultations de la notice

616

Téléchargements de fichiers

832